Hjem › Småcellet lungekræft
Småcellet lungekræft kliniske forsøg rekrutterer i USA
98 studier for Småcellet lungekræft rekrutterer deltagere på steder over hele USA.
Byer med flest studier
- Houston, TX26 studier
- Arlington, VA23 studier
- Boston, MA21 studier
- New York City, NY21 studier
- Nashville, TN20 studier
- Los Angeles, CA20 studier
- Orlando, FL15 studier
- Dallas, TX13 studier
- St. Louis, MO13 studier
- Cleveland, OH13 studier
- Detroit, MI12 studier
- Washington, DC12 studier
- Chicago, IL12 studier
- Baltimore, MD11 studier
- San Antonio, TX11 studier
- Philadelphia, PA10 studier
- Seattle, WA10 studier
- Atlanta, GA9 studier
- Durham, NC9 studier
- Grand Rapids, MI9 studier
- Tampa, FL9 studier
- Queens, NY9 studier
- Edison, NJ9 studier
- Indianapolis, IN9 studier
- Akron, OH8 studier
- Aurora, CO8 studier
- Columbus, OH8 studier
- Cedar Rapids, IA8 studier
- Miami, FL8 studier
- Omaha, NE8 studier
- Portland, OR8 studier
- Austin, TX7 studier
- Louisville, KY7 studier
- New Haven, CT7 studier
- Lexington, KY7 studier
- Cincinnati, OH7 studier
- West Valley City, UT7 studier
- Denver, CO6 studier
- Clifton, NJ6 studier
- Irving, TX6 studier
Efter delstat
- Alabama10 studier
- Arizona9 studier
- Arkansas5 studier
- Californien36 studier
- Colorado16 studier
- Connecticut9 studier
- District of Columbia5 studier
- Florida36 studier
- Georgia12 studier
- Illinois21 studier
- Indiana12 studier
- Iowa8 studier
- Kansas3 studier
- Kentucky15 studier
- Maryland19 studier
- Massachusetts22 studier
- Michigan26 studier
- Minnesota9 studier
- Missouri17 studier
- Nebraska10 studier
- New Jersey17 studier
- New Mexico3 studier
- New York31 studier
- North Carolina16 studier
- Ohio28 studier
- Oklahoma4 studier
- Oregon9 studier
- Pennsylvania15 studier
- South Carolina7 studier
- South Dakota3 studier
- Tennessee24 studier
- Texas41 studier
- Utah11 studier
- Virginia30 studier
- Washington13 studier
- Wisconsin11 studier
Nyligt opdaterede studier
Officiel studietekst (engelsk)
A Study to Evaluate the Optimal Dose, Adverse Events and Change in Disease Activity of Intravenous ABBV-706 in Combination With Atezolizumab Versus Standard of Care as First-Line Treatment in Adult Participants With Previously Untreated Extensive Stage Small Cell Lung Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07155174Tissue Procurement and Natural History Study of People With Non-Small Cell Lung Cancer, Small Cell Lung Cancer, Extrapulmonary Small Cell Cancer, Pulmonary Neuroendocrine Tumors, and Thymic Epithelial Tumors
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT02146170Prospective Multiomic Analysis in Small-Cell Lung Cancer
RekruttererObservationsstudie
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT07795411Autologous B7-H3 Chimeric Antigen Receptor T Cells in Previously Treated Extensive-Stage Small Cell Lung Cancer With Recurrent or Refractory Disease
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 2. okt. 2026 · NCT07509034The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
RekruttererFase 1/2
Alder 12 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT04585750A Study of Mevrometostat for Treatment of Relapsed/Refractory SCLC, Castration Resistant Prostate Cancer, and Follicular Lymphoma
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 2. okt. 2026 · NCT03460977A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors
RekruttererFase 1
Alder 19 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT06586957177Lu-BetaBart in Patients With Relapsed/Refractory, Locally Advanced Inoperable, or Metastatic Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 1. okt. 2026 · NCT07189871DAREON ® -Lung-1: A Study in People With Advanced Small Cell Lung Cancer to Compare Obrixtamig Plus Atezolizumab, Carboplatin, and Etoposide Treatment With Standard Chemoimmunotherapy
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 29. sep. 2026 · NCT07472517Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07476287Symbiotic-Lung-04: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Extensive-Stage Small Cell Lung Cancer
RekruttererFase 2/3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07226999A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 28. sep. 2026 · NCT07099898DESTINY-PANTUMOUR04
RekruttererObservationsstudie
Alder 18 til 130 · Alle køn · Opdateret 25. sep. 2026 · NCT07124000A Study of KIVU-107 in Participants With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT07229313Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 24. sep. 2026 · NCT06047379A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
RekruttererFase 3
Alder 18 og opefter · Alle køn · Opdateret 23. sep. 2026 · NCT07365241Phase I Study of [225Ac]Ac-ETN029 in Patients With Advanced DLL3-expressing Solid Tumors
RekruttererFase 1
Alder 18 til 100 · Alle køn · Opdateret 22. sep. 2026 · NCT07006727Study of [212Pb]Pb-DOTAM-MAM279 ([212Pb]Pb-MP0712) in Patients With Small Cell Lung Cancer and Other DLL3 Expressing Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07278479A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 22. sep. 2026 · NCT07488676A Study of Therapeutic Drug Monitoring-Based Atezolizumab Dosing
RekruttererFase 1
Alder 18 til 120 · Alle køn · Opdateret 22. sep. 2026 · NCT06066138Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors
RekruttererFase 1
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05983432Study of Trilaciclib and Lurbinectidin
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 21. sep. 2026 · NCT05578326A Study of ASP388B Given by Itself and With Standard Therapies in Participants With Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 18. sep. 2026 · NCT07730021A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC
RekruttererFase 2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07459634A Study of YL201 in Combination With Other Anti-Cancer Therapies in Patients With Advanced Solid Tumors
RekruttererFase 1/2
Alder 18 og opefter · Alle køn · Opdateret 17. sep. 2026 · NCT07407933Fra ClinicalTrials.gov, data hentet 4. okt. 2026. Hver studie har sine egne kvalifikationskrav; studieteamet afgør, hvem der kan deltage.